Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers
A completed clinical trial sponsored by the University of Pennsylvania evaluated care coordination from hospital to home for cognitively imp…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia [Phase 1]
A Phase 1 study evaluating the effects of JNJ-54861911 on amyloid-beta processing in cerebrospinal fluid and plasma in Japanese participants…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease
A completed Duke University clinical trial evaluating novel retinal imaging biomarkers for detecting early Alzheimer's disease and related c…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Indiana University Dementia Screening Trial [NA]
Indiana University’s Dementia Screening Trial (NCT01699503) has completed and posted results for dementia/Alzheimer’s disease screening, inc…
-
FDA approval · 2019-01-08FDA Approved: RIVASTIGMINE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' generic rivastigmine via Original Application (ANDA). The product is indicated for the treatment of…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Triggered Palliative Care for Advanced Dementia [NA]
Clinical trial update for triggered palliative care in advanced dementia shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2019-01-02Clinical Trial Update: Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of AD-35 Tablet in patients with Alzheimer’s disease.
-
FDA approval · 2018-12-18FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for ARICEPT (donepezil hydrochloride) submitted by Eisai Inc., updating the product labeling.
-
FDA approval · 2018-12-18FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for rivastigmine submitted by Sandoz Inc. This action updates rivastigmine's regulatory status t…
-
FDA approval · 2018-12-18FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
The FDA approved a supplemental application for ARICEPT (donepezil hydrochloride) by Eisai Inc. This action updates the product's labeling p…
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Side Effects of Newer Antipsychotics in Older Adults [Phase 4]
Phase 4 clinical trial update examining side effects of newer antipsychotics in older adults.
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update evaluating dopaminergic therapy in patients with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial of masitinib (AB1010) in mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study [Phase 3]
Phase 3 trial evaluating intepirdine (RVT-101) in mild-to-moderate Alzheimer's disease patients on donepezil completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating the efficacy and safety of PF 04494700 in mild to moderate Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo [Phase 2]
Phase 2 proof-of-concept study comparing BI 409306 to placebo in Alzheimer disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease [Phase 2]
Phase 2a dose-finding and PK/PD study of ANAVEX2-73 in Alzheimer's disease completed.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: Imaging Tau in Alzheimer's Disease and Normal Aging [Phase 2]
Phase 2 clinical trial related to imaging tau in Alzheimer's disease and normal aging has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. [Phase 2]
Phase 2 clinical trial update for BI 409306 in cognitive impairment due to Alzheimer’s disease; results posted after completion.
-
FDA approval · 2018-11-02FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for memantine hydrochloride (Actavis Pharma, Inc.) under NDA 021487. This action updates the approve…
-
CLINICAL_TRIALS research · 2018-11-02Clinical Trial Update: Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD [Phase 4]
Phase 4 trial assessing how FBB PET amyloid imaging changes diagnosis in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease [NA]
A completed clinical trial investigating the effect of walking on brain fuel consumption in individuals with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease [Phase 3]
Phase 3 clinical trial of GV-971 (sodium oligomannurarate) for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a specialized diet plan combined with cellular repair therapy to reduce inflammation in patients with mi…
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016) [Phase 1]
Phase 1 open-label study of MK-8931 in participants with hepatic impairment; results completed with conditions including amnestic mild cogni…